Hanneke Later-Nijland, a lawyer and partner at Genome Lawyers, as well as the founder of The Genotype Network, reflects on international developments in the biopharmaceutical sector. The world is constantly changing, not only in the Netherlands but also in Europe, the United States and, in particular, China. In her daily work, Hanneke Later-Nijland can see which developments are having a concrete impact on the biopharmaceutical sector. ‘’As well as the familiar components of the pharmaceutical industry, such as complex legislation and regulations, innovative treatments, cell and gene therapy, and affordability issues, current geopolitical tensions and power shifts have been added to the mix. This naturally has an impact on the industry’’, says Later-Nijland. ‘’This requires a clear vision, both in the interests of the Netherlands and Europe.’’